Patents by Inventor Stacey L. Schultz-Cherry

Stacey L. Schultz-Cherry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9221874
    Abstract: The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.
    Type: Grant
    Filed: January 24, 2012
    Date of Patent: December 29, 2015
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • Patent number: 9198965
    Abstract: The present disclosure generally relates to peptides having adjuvant properties, vaccines comprising the adjuvant peptides, and their use in prophylaxis or therapy for influenza. More particularly, the invention relates to adjuvant peptides that induce aggregation of influenza virus. The peptides can be included in influenza vaccines to increase the immune response to the vaccine.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: December 1, 2015
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • Publication number: 20130190228
    Abstract: The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.
    Type: Application
    Filed: January 24, 2012
    Publication date: July 25, 2013
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • Publication number: 20120189581
    Abstract: The invention provides a composition comprising an amount of a live attenuated or avirulent Toxoplasma gondii strain or a soluble extract thereof or a soluble extract of a wild-type T. gondii strain effective to inhibit or prevent heterologous microbial pathogen infection or replication, or one or more symptoms or manifestations of the microbial pathogen infection or replication, and methods of making or using the compositions.
    Type: Application
    Filed: July 23, 2010
    Publication date: July 26, 2012
    Inventors: Stacey L. Schultz-Cherry, Laura Knoll, Lori Neal, Kevin O'Brien
  • Patent number: 8129499
    Abstract: The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: March 6, 2012
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • Publication number: 20100041604
    Abstract: The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.
    Type: Application
    Filed: June 15, 2009
    Publication date: February 18, 2010
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • Publication number: 20100040642
    Abstract: The present disclosure generally relates to peptides having adjuvant properties, vaccines comprising the adjuvant peptides, and their use in prophylaxis or therapy for influenza. More particularly, the invention relates to adjuvant peptides that induce aggregation of influenza virus. The peptides can be included in influenza vaccines to increase the immune response to the vaccine.
    Type: Application
    Filed: June 15, 2009
    Publication date: February 18, 2010
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • Patent number: 7381524
    Abstract: A serological method to detect exposure to turkey astrovirus-2 (TAsV-2) is provided.
    Type: Grant
    Filed: October 10, 2003
    Date of Patent: June 3, 2008
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Stacey L. Schultz-Cherry, Matthew Koci